Discordant regulation of CRP and NT-proBNP plasma levels after electrical cardioversion of persistent atrial fibrillation

被引:36
|
作者
Buob, A [1 ]
Jung, J [1 ]
Siaplaouras, S [1 ]
Neuberger, HR [1 ]
Mewis, C [1 ]
机构
[1] Univ Klinikum Saarlandes, Innere Med Klin 3, D-66421 Homburg, Germany
来源
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 2006年 / 29卷 / 06期
关键词
atrial fibrillation; cardioversion; CRP; NT-proBNP;
D O I
10.1111/j.1540-8159.2006.00401.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: B-type natriuretic peptide (BNP) and C-reactive protein (CRP) have been suggested to be prognostically relevant markers in patients with cardiovascular disease. Additionally, BNP and CRP plasma levels seem to be independently elevated in patients with atrial fibrillation (AF). However, there are only sparse data about the significance and temporal course of these plasma markers after restoration of sinus rhythm (SR). Methods: We performed a prospective study in consecutive patients with symptomatic atrial fibrillation. NT-proBNP and CRP plasma levels were measured before and one month after electrical cardioversion (CV). Patients with infections, an acute coronary syndrome, or surgery 4 weeks prior to CV, were excluded. Result: Twenty-five patients (men 84%, age 66 +/- 8 years, duration of AF 90 +/- 75 days, left ventricular ejection fraction 0.57 +/- 0.11) were analyzed. At follow-up (33 +/- 6 days after CV) 14 patients (56%) were in SR and 11 patients (44%) in AF. In patients with SR there was a significant reduction of NT-proBNP levels (baseline 1647 +/- 1272 pg/mL, follow-up 772 +/- 866 pg/mL, P < 0.05), even in a subgroup of patients (n = 10) with normal left ventricular ejection fraction (1262 +/- 538 vs 413 +/- 344 pg/mL, P < 0.001). CRP levels in patients with SR were similar at baseline and at follow-up (3.5 +/- 3.6 vs 3.2 +/- 2.5 mg/L, P = 0.8). Conclusion: We conclude that even in patients with normal left ventricular ejection fraction restoration of sinus rhythm leads to a significant reduction of NT-proBNP plasma levels. In contrast, CRP plasma levels seem not to be influenced during the first 4 weeks after electrical cardioversion.
引用
收藏
页码:559 / 563
页数:5
相关论文
共 50 条
  • [31] The role of NT-proBNP in screening for atrial fibrillation in hypertensive disease
    Sado, Gina
    Gudmundsdottir, Katrin Kemp
    Bonander, Carl
    Ekstrom, Mattias
    Engdahl, Johan
    Svennberg, Emma
    IJC HEART & VASCULATURE, 2024, 55
  • [32] Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes
    Buettner, Petra
    Schumacher, Katja
    Dinov, Borislav
    Zeynalova, Samira
    Sommer, Philipp
    Bollmann, Andreas
    Husser, Daniela
    Hindricks, Gerhard
    Kornej, Jelena
    HEART RHYTHM, 2018, 15 (08) : 1132 - 1137
  • [33] Biomarkers for the detection of covert atrial fibrillation after ischemic stroke: NT-proBNP or BNP?
    Shiroto, Hiroshi
    Hagii, Joji
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2025, 34 (06):
  • [34] Placental Expression of proBNP/NT-proBNP and Plasma Levels of NT-proBNP in Early- and Late-Onset Preeclampsia
    Junus, Katja
    Wikstrom, Anna-Karin
    Larsson, Anders
    Olovsson, Matts
    AMERICAN JOURNAL OF HYPERTENSION, 2014, 27 (09) : 1225 - 1230
  • [35] Predicting Atrial Fibrillation with High Risk of Embolization with Atrial Strain and NT-proBNP
    Jorge Pagola
    Jesus Juega
    Jaume Francisco-Pascual
    Alejandro Bustamante
    Anna Penalba
    Elena Pala
    Maite Rodriguez
    Mercedes De Lera-Alfonso
    Juan F. Arenillas
    Juan Antonio Cabezas
    Francisco Moniche
    Reyes de Torres
    Joan Montaner
    Teresa González-Alujas
    Jose Alvarez-Sabin
    Carlos A. Molina
    Translational Stroke Research, 2021, 12 : 735 - 741
  • [36] Predicting Atrial Fibrillation with High Risk of Embolization with Atrial Strain and NT-proBNP
    Pagola, Jorge
    Juega, Jesus
    Francisco-Pascual, Jaume
    Bustamante, Alejandro
    Penalba, Anna
    Pala, Elena
    Rodriguez, Maite
    De Lera-Alfonso, Mercedes
    Arenillas, Juan F.
    Cabezas, Juan Antonio
    Moniche, Francisco
    de Torres, Reyes
    Montaner, Joan
    Gonzalez-Alujas, Teresa
    Alvarez-Sabin, Jose
    Molina, Carlos A.
    TRANSLATIONAL STROKE RESEARCH, 2021, 12 (05) : 735 - 741
  • [37] Elevated NT-proBNP is associated with unfavorably altered plasma fibrin clot properties in atrial fibrillation
    Matusik, Pawel T.
    Matusik, Patrycja S.
    Kornacewicz-Jach, Zdzislawa
    Malecka, Barbara
    Zabek, Andrzej
    Undas, Anetta
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 243 : 244 - 250
  • [38] Plasma NT-proANP in patients with persistent atrial fibrillation who underwent successful cardioversion
    Bartkowiak, Radoslaw
    Wozakowska-Kaplon, Beata
    Janiszewska, Grazyna
    KARDIOLOGIA POLSKA, 2010, 68 (01) : 48 - 54
  • [39] Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation
    Lidia Staszewsky
    Jennifer M. T. A. Meessen
    Deborah Novelli
    Ursula-Henrike Wienhues-Thelen
    Marcello Disertori
    Aldo P. Maggioni
    Serge Masson
    Gianni Tognoni
    Maria Grazia Franzosi
    Donata Lucci
    Roberto Latini
    BMC Cardiovascular Disorders, 21
  • [40] Maintainance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation - A reply
    Plewan, A
    EUROPEAN HEART JOURNAL, 2002, 23 (07) : 586 - 586